Acerus Pharmaceuticals (ASPCQ)
OTHER OTC:ASPCQ
Holding ASPCQ?
Track your performance easily

Acerus Pharmaceuticals (ASPCQ) Financial Statements

0 Followers

Acerus Pharmaceuticals Financial Overview

Acerus Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Acerus Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 770.00K$ 748.00K$ 782.00K$ 738.00K$ 587.00K
Gross Profit$ 568.00K$ 267.00K$ 531.00K$ 345.00K$ 98.00K
EBIT$ -2.65M$ -6.68M$ -5.48M$ -9.09M$ -3.89M
EBITDA-$ -6.62M$ -5.42M$ -9.01M$ -3.81M
Net Income Common Stockholders$ -4.17M$ -7.93M$ -6.95M$ -9.02M$ -4.90M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.02M$ 1.29M$ 3.56M$ 2.16M$ 2.27M
Total Assets$ 47.67M$ 45.43M$ 47.77M$ 9.65M$ 11.35M
Total Debt$ 46.13M$ 40.36M$ 35.32M$ 23.61M$ 17.01M
Net Debt$ 43.11M$ 39.07M$ 31.76M$ 21.45M$ 14.74M
Total Liabilities$ 61.56M$ 57.14M$ 52.38M$ 35.67M$ 29.95M
Stockholders Equity$ -13.89M$ -11.71M$ -4.61M$ -26.01M$ -18.61M
Cash Flow-
Free Cash Flow$ -20.49M$ -6.86M$ -5.36M$ -7.32M$ -4.51M
Operating Cash Flow$ -18.59M$ -6.05M$ -4.66M$ -7.25M$ -4.51M
Investing Cash Flow$ -1.90M$ -813.00K$ -695.00K$ -60.00K$ 0.00
Financing Cash Flow$ 21.35M$ 4.58M$ 6.76M$ 7.20M$ 4.18M
Currency in USD

Acerus Pharmaceuticals Earnings and Revenue History

Acerus Pharmaceuticals Debt to Assets

Acerus Pharmaceuticals Cash Flow

Acerus Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis